Nasal Decongestants

DBCAT000818Pharmacologic class

Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of... A DrugBank category of 9 drugs. 7 of them are approved.

Also known as: Agents, Nasal Vasoconstrictor · Decongestants · Decongestants, Nasal · Nasal Vasoconstrictor Agents · Nasal Vasoconstrictors
Drugs: Cirazoline
Naphazoline
Oxymetazoline
Phenylephrine
Phenylpropanolamine
Pseudoephedrine
Synephrine
Tetryzoline
Xylometazoline

What you can answer from here — as of March 13, 2023

9DrugsEach linked to its full drug card

Listed above

26Drug targetsEvery drug–target pair in the class, with bond type

10,297Marketed productsAcross the regions we cover, with dosage forms and routes

17Routes of administrationHow the drugs in this class are given

Which targets do Nasal Decongestants share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account